A Two Part, Phase I-IIa Study Evaluating MK1775 in Combination With Topotecan/Cisplatin in Adult Patients With Cervical Cancer.

Trial Profile

A Two Part, Phase I-IIa Study Evaluating MK1775 in Combination With Topotecan/Cisplatin in Adult Patients With Cervical Cancer.

Discontinued
Phase of Trial: Phase I/II

Latest Information Update: 06 Feb 2015

At a glance

  • Drugs AZD-1775 (Primary) ; Cisplatin; Topotecan
  • Indications Cervical cancer
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Merck Sharp & Dohme
  • Most Recent Events

    • 05 May 2011 Planned End Date changed from 1 Aug 2011 to 1 Oct 2011 as reported by ClinicalTrials.gov.
    • 04 Mar 2011 Status changed from recruiting to active, no longer recruiting.
    • 24 Feb 2011 Planned end date changed from 1 May 2012 to 1 Aug 2011 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top